Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
- PMID: 28536305
- DOI: 10.1158/1078-0432.CCR-17-0285
Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
Abstract
Purpose: Pancreatic cancer is a severe indication with short expected survival despite surgery and/or combination chemotherapeutics. Checkpoint blockade antibodies are approved for several cancer indications, but pancreatic cancer has remained refractory. However, there are clinical data suggesting that stimulation of the CD40 pathway may be of interest for these patients. Oncolytic viruses armed with immunostimulatory genes represent an interesting approach. Herein, we present LOAd703, a designed adenovirus armed with trimerized CD40L and 4-1BBL that activates the CD40 and 4-1BB pathways, respectively. As many cells in the tumor stroma, including stellate cells and the infiltrating immune cells, express CD40 and some 4-1BB, we hypothesize that LOAd703 activates immunity and simultaneously modulates the biology of the tumor stroma.Experimental Design: Tumor, stellate, endothelial, and immune cells were infected by LOAd703 and investigated by flow cytometry, proteomics, and functional analyses.Results: LOAd703-infected pancreatic cell lines were killed by oncolysis, and the virus was more effective than standard-of-care gemcitabine. In in vivo xenograft models, LOAd703 efficiently reduced established tumors and could be combined with gemcitabine for additional effect. Infected stellate and tumor cells reduced factors that promote tumor growth (Spp-1, Gal-3, HGF, TGFβ and collagen type I), while chemokines were increased. Molecules involved in lymphocyte migration were upregulated on infected endothelial cells. Dendritic cells were robustly stimulated by LOAd703 to produce costimulators, cytokines and chemokines, and such DCs potently expanded both antigen-specific T cells and NK cells.Conclusions: LOAd703 is a potent immune activator that modulates the stroma to support antitumor responses. Clin Cancer Res; 23(19); 5846-57. ©2017 AACR.
©2017 American Association for Cancer Research.
Similar articles
-
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy.Cancer Immunol Immunother. 2021 Oct;70(10):2851-2865. doi: 10.1007/s00262-021-02895-7. Epub 2021 Mar 5. Cancer Immunol Immunother. 2021. PMID: 33666760 Free PMC article.
-
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment.Gene Ther. 2017 Feb;24(2):92-103. doi: 10.1038/gt.2016.80. Epub 2016 Dec 1. Gene Ther. 2017. PMID: 27906162 Free PMC article.
-
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1.J Immunol. 2019 Feb 1;202(3):787-798. doi: 10.4049/jimmunol.1800717. Epub 2019 Jan 7. J Immunol. 2019. PMID: 30617223
-
Advances in oncolytic adenovirus therapy for pancreatic cancer.Cancer Lett. 2018 Oct 10;434:56-69. doi: 10.1016/j.canlet.2018.07.006. Epub 2018 Jul 5. Cancer Lett. 2018. PMID: 29981812 Review.
-
Is oncolytic adenoviral-mediated immunotherapy through p53-overexpression the solution to refractory pancreatic ductal adenocarcinoma?Expert Rev Gastroenterol Hepatol. 2024 Jun;18(6):223-226. doi: 10.1080/17474124.2024.2363222. Epub 2024 Jun 17. Expert Rev Gastroenterol Hepatol. 2024. PMID: 38818792 Review.
Cited by
-
Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy.Int J Mol Sci. 2024 Jan 18;25(2):1180. doi: 10.3390/ijms25021180. Int J Mol Sci. 2024. PMID: 38256250 Free PMC article. Review.
-
Therapeutic Implementation of Oncolytic Viruses for Cancer Immunotherapy: Review of Challenges and Current Clinical Trials.J Biomed Sci Res. 2022;4(2):164. doi: 10.36266/JBSR/164. Epub 2022 Oct 20. J Biomed Sci Res. 2022. PMID: 36381110 Free PMC article.
-
Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma.Oncoimmunology. 2024 Feb 27;13(1):2322173. doi: 10.1080/2162402X.2024.2322173. eCollection 2024. Oncoimmunology. 2024. PMID: 38419758 Free PMC article.
-
Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC.Mol Ther. 2019 Nov 6;27(11):1906-1918. doi: 10.1016/j.ymthe.2019.07.019. Epub 2019 Aug 5. Mol Ther. 2019. PMID: 31466933 Free PMC article.
-
Single-cell RNA sequencing reveals a strong connection between Gadd45g upregulation and oncolytic HSV infection in tumor tissue.Mol Ther Oncolytics. 2021 Oct 20;23:330-341. doi: 10.1016/j.omto.2021.10.006. eCollection 2021 Dec 17. Mol Ther Oncolytics. 2021. PMID: 34786476 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous